People · Operator

Brian Bernick

Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Other Health Care

2
Companies
4
Filings
$37.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Micron Biomedical, Inc.BiotechnologySeries A$32.0M$63.4M2023
VitaMedMD, LLCOther Health CareSeed$5.2M$81.2M2010
Operator network

Brian Bernick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Matthew Goldman · 5 companies · 1 sharedMatthew GoldmanIdean Marvasty · 2 companies · 1 sharedIdean MarvastyMark Prausnitz · 2 companies · 1 sharedMark PrausnitzSteven Damon · 2 companies · 1 sharedSteven DamonBas Van Buijtenen · 1 companies · 1 sharedBas Van BuijtenenDevin McAllister · 1 companies · 1 sharedDevin McAllisterHenry Sebastien · 1 companies · 1 sharedHenry SebastienLabeeb Abboud · 1 companies · 1 sharedLabeeb AbboudSebastien Henry · 1 companies · 1 sharedSebastien HenrySteve Damon · 1 companies · 1 sharedSteve DamonRobert Finizio · 4 companies · 1 sharedRobert FinizioAlan Wurtzel · 3 companies · 1 sharedAlan WurtzelJohn Milligan · 1 companies · 1 sharedJohn MilliganNick Segal · 1 companies · 1 sharedNick SegalMicron Biomedical, Inc. · $32.0M raisedMicron Biomedical, In…VitaMedMD, LLC · $5.2M raisedVitaMedMD, LLCBrian BernickBB
Brian Bernick Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Brian Bernick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Matthew Goldman15
Robert Finizio14
Alan Wurtzel13
Steven Damon12
Idean Marvasty12
Mark Prausnitz12
Sebastien Henry11
John Milligan11
Nick Segal11
Henry Sebastien11
Devin McAllister11
Bas Van Buijtenen11
Steve Damon11
Labeeb Abboud11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.